Portal de Periódicos da CAPES

Genetic susceptibility to keloid disease and transforming growth factor β2 polymorphisms

2002; Elsevier BV; Volume: 55; Issue: 4 Linguagem: Inglês

10.1054/bjps.2002.3853

1465-3087

Ardeshir Bayat, Oliver Bock, U. Mrowietz, William Ollier, Mark W. J. Ferguson,

Dermatological and Skeletal Disorders

Keloid disease (KD) is a benign fibroproliferative scarring condition of unknown aetiopathogenesis. There is a familial predisposition to keloid scarring. The genes involved in the pathogenesis of abnormal dermal scarring have yet to be identified. Transforming growth factor beta (TGF beta) is a family of multifunctional cytokines, which play a central role in wound healing and fibrosis. The TGF beta 2 isoform is a member of this cytokine family and has previously been implicated in KD pathogenesis. We tested for an association between KD and two novel polymorphisms within the TGF beta 2 gene: an insertion polymorphism within the 59-untranslated region, 109 base pairs away from the initiation codon, and a single nucleotide polymorphism in exon one. We examined DNA samples from 101 patients with KD and 187 ethnically matched controls. No statistically significant differences in TGF beta 2 genotype or allele frequency distribution were observed between the patients and the controls. We believe this to be the first report of a case-control association study in KD and TGF beta 2 polymorphisms.